Evaluation of Aortic Calcification With Lanthanum Carbonate vs. Calcium-Based Phosphate Binders in Maintenance Hemodialysis Patients With Type 2 Diabetes Mellitus: An Open-Label Randomized Controlled Trial

Therapeutic Apheresis and Dialysis

Volumn 18, Issue 4, 2014, Pages 353-360

  Wada, Kentaro ^a   Wada, Yuko ^a  

^a Division of Cardiology   (Japan)

Author keywords

Calcium; Diabetes mellitus; Hemodialysis; Lanthanum carbonate; Vascular calcification

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; CALTAN; HEMOGLOBIN A1C; LANTHANUM CARBONATE; PHOSPHATE BINDING AGENT; UNCLASSIFIED DRUG; CHELATING AGENT; LANTHANUM; PHOSPHATE;

ADULT; AORTA CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE DISEASE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE TITRATION; DRUG SCREENING; FEMALE; HEMATOLOGY ANALYZER; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL SERVICE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AGED; AORTIC DISEASES; CALCINOSIS; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

AGED; AORTIC DISEASES; CALCINOSIS; CALCIUM CARBONATE; CHELATING AGENTS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; LANTHANUM; MALE; MIDDLE AGED; PHOSPHATES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84905925189     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12153     Document Type: Article

References (35)

1. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001;60:472-479.
2. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R III. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979;66:790-796.
3. Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 1993;16:31-36.
4. Ohya M, Otani H, Kimura K etal. Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol 2011;15:877-883.
5. Okuno S, Ishimura E, Kitatani K etal. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007;49:417-425.
6. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
7. Shioi A, Taniwaki H, Jono S etal. Mönckeberg's medial sclerosis and inorganic phosphate in uremia. Am J Kidney Dis 2001;38(Suppl 1):S47-49.
8. Nakai S, Akiba T, Kazama J etal. Patient Registration Committee of the Japanese Society for Dialysis Therapy, Tokyo, Japan: effects of serum calcium, phosphorus, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Aper Dial 2008;12:49-54.
9. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-617.
10. Goodman WG, Goldin J, Kuizon BD etal. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
11. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H. Vascular calcification and inorganic phosphate. Am J Kidney Dis 2001;38(Suppl 1):S34-37.
12. Raggi P, Boulay A, Chasan-Taber S etal. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695-701.
13. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004;19:1489-1496.
14. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
15. Block GA, Spiegel DM, Ehrlich J etal. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005;68:1815-1824.
16. Locatelli F, D'Amico M, Pontoriero G. Lanthanum carbonate (Shire). Idrugs 2003;6:688-695.
17. Shigematsu T, Lanthanum Carbonate Research Group. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis. Ther Apher Dial 2008;12:55-61.
18. Hutchison AJ, Barnett ME, Krause R, Kwan JT, Siami GA. SPD405-309 Lanthanum Study Group: long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment. Nephron Clin Pract 2008;110:c15-23.
19. Sprague SM, Ross EA, Nath SD, Zhang P, Pratt RD, Krause R. Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study. Clin Nephorol 2009;72:252-258.
20. Neven E, Dams G, Postnov A etal. Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats. Nephrol Dial Transplant 2009;24:1790-1799.
21. Shi YL, Wang LW, Huang J, Gou BD, Zhang TL, Wang K. Lanthanum suppresses osteoblastic differentiation via pertussis toxin-sensitive G protein signaling in rat vascular smooth muscle cells. J Cell Biochem 2009;108:1184-1191.
22. Toussaint ND, Lau KK, Polkinghorne KR, Kerr PG. Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: a pilot randomized controlled trial. Nephrology (Carlton) 2011;16:290-298.
23. Sakata N, Takeuchi K, Noda K etal. Calcification of the medial layer of the internal thoracic artery in diabetic patients: relevance of glycoxidation. J Vasc Res 2003;40:567-574.
24. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells thorough RAGE/p38 MAPK. J Vasc Res 2009;46:572-580.
25. Ishimura E, Okuno S, Kitatani K etal. Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients-importance of glycaemic control. Diabetologia 2002;45:1446-1448.
26. Kashiwagi A, Kasuga M, Araki E etal. International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. Diabetol Int 2012;3:8-10.
27. Kimura K, Saika Y, Otani H, Fujii R, Mune M, Yukawa S. Factors associated with calcification of the abdominal aorta in hemodialysis patients. Kidney Int 1999;71(Suppl):S238-241.
28. Schmermund A, Baumgart D, Möhlenkamp S etal. Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler Thromb Vasc Biol 2001;21:421-426.
29. Zhou YB, Jin SJ, Cai Y etal. Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats. Exp Biol Med (Maywood) 2009;234:908-917.
30. Ren X, Shao H, Wei Q, Sun Z, Liu N. Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res 2009;37:847-854.
31. Ishimura E, Okuno S, Taniwaki H etal. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control. Kidney Blood Press Res 2008;31:10-15.
32. Guérin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-1021.
33. Slatopolsky E, Finch J, Clay P etal. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000;58:753-761.
34. Manabe R, Fukami K, Ando R etal. Effects of switching from calcium carbonate to lanthanum carbonate on bone mineral metabolism in hemodialysis patients. Ther Apher Dial 2013;17(Suppl):35-40.
35. Gotoh J, Kukita K, Tsuchihashi S etal. Study of prolonged administration of lanthanum carbonate in dialysis patients. Ther Apher Dial 2013;17(Suppl):9-14.